NOTICE: Virtual registration will CLOSE on Friday, June 7, 2024. On-site, walk-in registration is still available on day-of.
The Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine (AIPM), co-sponsored by Pfizer Inc, Northeastern University and the American Statistical Association (ASA), is intended to provide a forum for major stakeholders to have a dialogue on pertinent issues that have policy implications for proper implementation of this emerging technology.
This event is designed to serve as a platform for:
- Statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine
- Fostering collaboration among industry, academia, regulatory agencies, and professional associations
- Discussing policy implications for proper implementation of AI in promoting public health
The theme of the 2024 AIPM Symposiums is Generative AI in Medical Research & Drug Development: Hype or Reality?
Registration for this event includes complementary registration for the Day 1 Tutorials and the Evening Reception hosted by Northeastern University. Anyone who is not registered for the event will not be admitted into the Day 1 Tutorials or the Evening Reception.
Hotel:
We have partnered with the Colonnade Hotel to reserve a limited number of rooms at a reduced rate for this event. Hotel registration can be completed here until the room block is at capacity.
Click Below to View:
If you have any questions about the event or registration, please contact us at AIPM@northeastern.edu.
